TY - JOUR
T1 - Correction
T2 - Favipiravir and/or nitazoxanide: a randomized, double-blind, placebo-controlled trial of early therapy in COVID-19 in health workers, their household members, and patients treated at IMSS (FANTAZE) (Trials, (2022), 23, 1, (583), 10.1186/s13063-022-06533-0)
AU - Smith, Tania A.
AU - Hoyo-Vadillo, Carlos
AU - Adom, Akosua Agyeman
AU - Favari-Perozzi, Liliana
AU - Gastine, Silke
AU - Dehbi, Hakim Moulay
AU - Villegas-Lara, Beatriz
AU - Mateos, Eduardo
AU - González, Yessica Sara Pérez
AU - Navarro-Gualito, Maria D.
AU - Cruz-Carbajal, Alejandra S.
AU - Cortes-Vazquez, Miguel A.
AU - Bekker-Méndez, Carolina
AU - Aguirre-Alvarado, Charmina
AU - Aguirre-Gil, Gisela
AU - Delgado-Pastelin, Lucero
AU - Owen, Andrew
AU - Lowe, David
AU - Standing, Joseph
AU - Escobedo, Jorge
N1 - Publisher Copyright:
© The Author(s) 2023.
PY - 2023/12
Y1 - 2023/12
N2 - The original publication of this article [1] erroneously contained "2X2 design" in the title whilst the study itself did not include a 2 × 2 design. The original article has been updated.
AB - The original publication of this article [1] erroneously contained "2X2 design" in the title whilst the study itself did not include a 2 × 2 design. The original article has been updated.
UR - http://www.scopus.com/inward/record.url?scp=85159793539&partnerID=8YFLogxK
U2 - 10.1186/s13063-023-07364-3
DO - 10.1186/s13063-023-07364-3
M3 - Comentario/Debate
C2 - 37218017
AN - SCOPUS:85159793539
SN - 1745-6215
VL - 24
JO - Trials
JF - Trials
IS - 1
M1 - 347
ER -